rivastigmine
Drug Details
- Generic Name
- rivastigmine
- Brand Names
- Rivastigmine, Exelon
- Application Number
- NDA022083
- Sponsor
- Sandoz Inc
- NDC Codes
- 13
- Dosage Forms
- PATCH, EXTENDED RELEASE, PATCH, POWDER
- Routes
- TRANSDERMAL
- Active Ingredients
- RIVASTIGMINE
Indications and Usage
1 INDICATIONS AND USAGE Rivastigmine transdermal system is an acetylcholinesterase inhibitor indicated for treatment of: • Mild, moderate, and severe dementia of the Alzheimer’s type (AD). ( 1.1 ) • Mild-to-moderate dementia associated with Parkinson’s disease (PD). ( 1.2 ) 1.1 Alzheimer’s Disease Rivastigmine transdermal system is indicated for the treatment of dementia of the Alzheimer’s type (AD). Efficacy has been demonstrated in patients with mild, moderate, and severe Alzheimer’s disease. 1.2 Parkinson’s Disease Dementia Rivastigmine transdermal system is indicated for the treatment of mild-to-moderate dementia associated with Parkinson’s disease (PDD).